Ultrastructural distribution of PMP22 in Charcot-Marie-Tooth disease type 1A

被引:50
|
作者
Haney, C
Snipes, GJ
Shooter, EM
Suter, U
Garcia, C
Griffin, JW
Trapp, BD
机构
[1] CLEVELAND CLIN FDN, DEPT NEUROSCI, CLEVELAND, OH 44195 USA
[2] STANFORD UNIV, SCH MED, DEPT NEUROBIOL, STANFORD, CA 94305 USA
[3] STANFORD UNIV, SCH MED, DEPT NEUROPATHOL, STANFORD, CA 94305 USA
[4] SWISS FED INST TECHNOL, ETH HONGGERBERG, DEPT CELL BIOL, CH-8093 ZURICH, SWITZERLAND
[5] LOUISIANA STATE UNIV, MED CTR, SCH MED, DEPT NEUROL, NEW ORLEANS, LA 70112 USA
[6] LOUISIANA STATE UNIV, MED CTR, SCH MED, DEPT PATHOL, NEW ORLEANS, LA 70112 USA
[7] JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROL, NEUROMUSCULAR DIV, BALTIMORE, MD 21287 USA
关键词
D O I
10.1097/00005072-199603000-00004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Peripheral Myelin Protein-22 (PMP22) is a membrane glycoprotein which represents up to 5% of total protein in myelin of peripheral nerves. Mutations affecting the PMP22 gene have been linked to the inherited peripheral neuropathies Charcot-Marie-Tooth disease type 1A (CMT1A; duplications and point mutations), Dejerine-Sottas syndrome (DSS; point mutations), and hereditary neuropathy with liability to pressure palsies (HNPP; deletions). In this study, we determined the ultrastructural distribution of PMP22 and other myelin proteins in normal human peripheral nervous system (PNS) nerves and in CMT1 patients with or without the CMT1A duplication on chromosome 17. Our results demonstrate that PMP22, P-0 protein, and myelin basic protein are present in compact myelin of all patients examined. PMP22 was also present in the plasma membrane of Schwann cells of unmyelinated fibers and onion bulbs. Although the precise biological role of PMP22 remains to be discovered, our results support the hypothesis that this protein serves multiple functions in Schwann cells.
引用
收藏
页码:290 / 299
页数:10
相关论文
共 50 条
  • [21] Comparison between Clinical Disabilities and Electrophysiological Values in Charcot-Marie-Tooth 1A Patients with PMP22 Duplication
    Kim, Young Hwa
    Chung, Hwa Kyung
    Park, Kee Duk
    Choi, Kyoung-Gyu
    Kim, Seung-Min
    Sunwoo, Il-Nam
    Choi, Young-Chul
    Lim, Jeong-Geun
    Lee, Kwang Woo
    Kim, Kwang-Kuk
    Lee, Dong Kuk
    Joo, In Soo
    Kwon, Ki-Han
    Gwon, Seok Beom
    Park, Jae Hyeon
    Kim, Dae-Seong
    Kim, Seung Hyun
    Kim, Woo-Kyung
    Suh, Bum Chun
    Kim, Sang-Beom
    Kim, Nam-Hee
    Sohn, Eun Hee
    Kim, Ok-Joon
    Kim, Hyun Sook
    Cho, Jung Hee
    Kang, Sa-Yoon
    Park, Chan-Ik
    Oh, Jiyoung
    Shin, Jong Hyu
    Chung, Ki Wha
    Choi, Byung-Ok
    JOURNAL OF CLINICAL NEUROLOGY, 2012, 8 (02): : 139 - 145
  • [22] PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker
    Nobbio, Lucilla
    Visigalli, Davide
    Radice, Davide
    Fiorina, Elisabetta
    Solari, Alessandra
    Lauria, Giuseppe
    Reilly, Mary M.
    Santoro, Lucio
    Schenone, Angelo
    Pareyson, Davide
    BRAIN, 2014, 137 : 1614 - 1620
  • [23] Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A
    Suzan Boutary
    Marie Caillaud
    Mévidette El Madani
    Jean-Michel Vallat
    Julien Loisel-Duwattez
    Alice Rouyer
    Laurence Richard
    Céline Gracia
    Giorgia Urbinati
    Didier Desmaële
    Andoni Echaniz-Laguna
    David Adams
    Patrick Couvreur
    Michael Schumacher
    Charbel Massaad
    Liliane Massaad-Massade
    Communications Biology, 4
  • [24] Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A
    Boutary, Suzan
    Caillaud, Marie
    El Madani, Mevidette
    Vallat, Jean-Michel
    Loisel-Duwattez, Julien
    Rouyer, Alice
    Richard, Laurence
    Gracia, Celine
    Urbinati, Giorgia
    Desmaele, Didier
    Echaniz-Laguna, Andoni
    Adams, David
    Couvreur, Patrick
    Schumacher, Michael
    Massaad, Charbel
    Massaad-Massade, Liliane
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [25] DUPLICATION OF THE PMP22 GENE IN 17P PARTIAL TRISOMY PATIENTS WITH CHARCOT-MARIE-TOOTH TYPE 1A NEUROPATHY
    ROA, BB
    GREENBERG, F
    GUNARATNE, P
    SAUER, CM
    LUBINSKY, MS
    KOZMA, C
    MECK, JM
    MAGENIS, RE
    SHAFFER, LG
    LUPSKI, JR
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 171 - 171
  • [26] PMP22 immunoreactivity on biopsied sural nerves in Charcot-Marie-Tooth disease 1A and hereditary neuropathy with liability to pressure palsies
    Vallat, JM
    Sindou, P
    Preux, PM
    Tabaraud, F
    Couratier, P
    Milor, AM
    Brice, A
    LeGuern, E
    NEUROLOGY, 1996, 46 (02) : 35004 - 35004
  • [27] A transgenic rat modet of Charcot-Marie-Tooth disease with increased PMP22 gene dosage
    Sereda, M
    Griffiths, IR
    Puhlhofer, A
    Magyar, JP
    Meink, HM
    Zimmermann, F
    Rossner, M
    Schneider, A
    Suter, U
    Nave, KA
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 : S1 - S1
  • [28] A unique point mutation in the PMP22 gene is associated with Charcot-Marie-Tooth disease and deafness
    Kovach, MJ
    Lin, JP
    Boyadjiev, S
    Campbell, K
    Mazzeo, L
    Herman, K
    Rimer, LA
    Frank, W
    Llewellyn, B
    Jabs, EW
    Gelber, D
    Kimonis, VE
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (06) : 1580 - 1593
  • [29] A novel PMP22 insertion mutation causing Charcot-Marie-Tooth disease type 3 A case report
    Han, Liang
    Huang, Yanjing
    Nie, Yuan
    Li, Jing
    Chen, Gang
    Tu, Shenghao
    Shen, Pan
    Chen, Chao
    MEDICINE, 2021, 100 (11) : E25163
  • [30] Overview of Charcot-Marie-Tooth disease type 1A
    Thomas, PK
    CHARCOT-MARIE-TOOTH DISORDERS, 1999, 883 : 1 - 5